Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Tambiciclib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SELLAS Life Sciences To Showcase SLS009 Survival Benefit
    SELLAS Life Sciences To Showcase SLS009 Survival Benefit

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165494/0/en/SELLAS-Life-Sciences-to-Present-In-Vivo-Preclinical-Data-Demonstrating-Statistically-Significant-Survival-Benefit-of-SLS009-in-T-Cell-Prolymphocytic-Leukemia-at-the-European-Societ.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share
    SELLAS Presents SLS009 Preclinical Data In ASXL1 CRC At ASCO
    SELLAS Presents SLS009 Preclinical Data In ASXL1 CRC At ASCO

    02 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/02/3091782/0/en/SELLAS-Presents-Preclinical-Efficacy-of-SLS009-in-ASXL1-Mutated-Colorectal-Cancer-at-2025-ASCO-Annual-Meeting.html

    GLOBENEWSWIRE
    02 Jun 2025
    Share Share
    Sellas Reports Overall Survival in Ph 2 Trial of SLS009 in r/r AML
    Sellas Reports Overall Survival in Ph 2 Trial of SLS009 in r/r AML

    08 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/08/3057624/0/en/SELLAS-Announces-Positive-Overall-Survival-in-Cohort-3-from-the-Ongoing-Phase-2-Trial-of-SLS009-in-r-r-AML.html

    GLOBENEWSWIRE
    08 Apr 2025
    Share Share